imidazole has been researched along with Movement Disorders in 1 studies
imidazole: RN given refers to parent cpd
1H-imidazole : An imidazole tautomer which has the migrating hydrogen at position 1.
Movement Disorders: Syndromes which feature DYSKINESIAS as a cardinal manifestation of the disease process. Included in this category are degenerative, hereditary, post-infectious, medication-induced, post-inflammatory, and post-traumatic conditions.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Nakagawa-Yagi, Y | 1 |
| Choi, DK | 1 |
| Ogane, N | 1 |
| Shimada, S | 1 |
| Seya, M | 1 |
| Momoi, T | 1 |
| Ito, T | 1 |
| Sakaki, Y | 1 |
1 other study available for imidazole and Movement Disorders
| Article | Year |
|---|---|
Discovery of a novel compound: insight into mechanisms for acrylamide-induced axonopathy and colchicine-induced apoptotic neuronal cell death.
Topics: Acrylamides; Apoptosis; Axons; Benzimidazoles; CELF Proteins; Colchicine; Cyclopentanes; Dose-Respon | 2001 |